Association between apolipoprotein E genotypes and cancer risk in patients with acquired immunodeficiency syndrome

Cancer Detect Prev. 2000;24(5):496-9.

Abstract

The apolipoprotein E (apoE) genotype was determined in 197 deceased acquired immunodeficiency syndrome (AIDS) patients treated at Ullevaal Hospital in Oslo, Norway. A full autopsy had been performed on all. Cancer had developed in 71 individuals, mainly lymphomas (46) and Kaposi's sarcomas (18). The apoE genotype distribution was consistent with Hardy-Weinberg equilibrium, and allele frequencies were in the typical Scandinavian range (6.9% apoE2; 75.6% apoE3; and 17.5% apoE4). Cancer cases had a significantly higher frequency of apoE4 alleles than noncancer cases (24.6% and 13.5%, respectively) and a lower frequency of apoE2 alleles (3.5% versus 8.7%). Background factors, such as survival from AIDS diagnosis, could not explain these differences. Our study thus indicates that apoE genotype affects the development of cancers among AIDS patients.

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Acquired Immunodeficiency Syndrome / genetics*
  • Adult
  • Alleles
  • Apolipoproteins E / genetics*
  • Female
  • Genotype
  • Humans
  • Lymphoma, AIDS-Related / genetics*
  • Male
  • Sarcoma, Kaposi / genetics*

Substances

  • Apolipoproteins E